EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-24 promotes atopic dermatitis-like inflammation through driving MRSA-induced allergic responses

Xinmin Qian iD, Meiyi Tong iD, Tianqing Zhang iD, Qingqing Li iD, Meng Hua, Nan Zhou, Wenwen Zeng iD

Protein & Cell · 08.03.2025 · 16 (3) · 188-210

DOI: 10.1093/procel/pwae030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein & Cell, online erschienen am 16.05.2024. Verfasst von Xinmin Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunology and School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Interleukins, Methicillin-Resistant Staphylococcus aureus, Inflammation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a prevalent inflammatory skin disorder in which patients experience recurrent eczematous lesions and intense itching. The colonization of Staphylococcus aureus (S. aureus) is correlated with the severity of the disease, but its role in AD development remains elusive. Using single-cell RNA sequencing, we uncovered that keratinocytes activate a distinct immune response characterized by induction of Il24 when exposed to methicillin-resistant S. aureus (MRSA). Further experiments using animal models showed that the administration of recombinant IL-24 protein worsened AD-like pathology. Genetic ablation of Il24 or the receptor Il20rb in keratinocytes alleviated allergic inflammation and atopic march. Mechanistically, IL-24 acted through its heterodimeric receptors on keratinocytes and augmented the production of IL-33, which in turn aggravated type 2 immunity and AD-like skin conditions. Overall, these findings establish IL-24 as a critical factor for onset and progression of AD and a compelling therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicInterleukinsMethicillin-Resistant Staphylococcus aureusInflammationStaphylococcal InfectionsHypersensitivityAnimalsMiceKeratinocytesHumansInterleukin-33Disease Models, AnimalMice, Inbred C57BLInterleukin-24

Stichwörter der Autor:innen

IL-24MRSAallergic inflammationatopic dermatitiskeratinocytes

Substanzen

InterleukinsInterleukin-33Interleukin-24

Autor:innen und Institutionen

  • Institute for Immunology and School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing 100084, China.
  • Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100084, China.
  • School of Life Sciences, Tsinghua University, Beijing 100084, China.
  • SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi Medical University, Taiyuan 030001, China.
  • Tsinghua-Peking Center for Life Sciences, Beijing 100084, China.
  • Beijing Key Laboratory for Immunological Research on Chronic Diseases, Beijing 100084, China.

ORCID-Profile: Xinmin Qian, Meiyi Tong, Tianqing Zhang, Qingqing Li, Wenwen Zeng

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Qian, X., Tong, M., Zhang, T., Li, Q., Hua, M., Zhou, N., & Zeng, W. (2025). IL-24 promotes atopic dermatitis-like inflammation through driving MRSA-induced allergic responses. Protein & Cell, 16(3), 188-210. https://doi.org/10.1093/procel/pwae030

Vancouver

Qian X, Tong M, Zhang T, Li Q, Hua M, Zhou N, et al. IL-24 promotes atopic dermatitis-like inflammation through driving MRSA-induced allergic responses. Protein & Cell. 2025;16(3):188-210. doi:10.1093/procel/pwae030

BibTeX
@article{Qian2025,
  author = {Qian, Xinmin and Tong, Meiyi and Zhang, Tianqing and Li, Qingqing and Hua, Meng and Zhou, Nan and Zeng, Wenwen},
  title = {IL-24 promotes atopic dermatitis-like inflammation through driving MRSA-induced allergic responses},
  journal = {Protein & Cell},
  year = {2025},
  volume = {16},
  number = {3},
  pages = {188--210},
  doi = {10.1093/procel/pwae030}
}
Kostenlos starten →